EUPRAXIA PHARMACEUTICALS INC (EPRX) Stock Analyst Ratings
NASDAQ:EPRX - Nasdaq - CA29842P1053 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to EPRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.24. This target is 52.57% above the current price.
EPRX was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EPRX.
In the previous month the buy percentage consensus was at a similar level.
EPRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-24 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-06-26 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-14 | Rodman & Renshaw | Initiate | Buy |